These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18339019)

  • 1. Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid.
    Kikuchi E; Yamazaki K; Kikuchi J; Hasegawa N; Hashimoto S; Ishizaka A; Nishimura M
    Respirology; 2008 Mar; 13(2):221-6. PubMed ID: 18339019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage.
    Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
    Clin Ther; 2007 Jan; 29(1):123-30. PubMed ID: 17379052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.
    Gotfried MH; Danziger LH; Rodvold KA
    J Antimicrob Chemother; 2003 Sep; 52(3):450-6. PubMed ID: 12888589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of telithromycin using bronchoscopic microsampling after single and multiple oral doses.
    Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
    Pulm Pharmacol Ther; 2007; 20(5):549-55. PubMed ID: 17127087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.
    Andrews J; Honeybourne D; Ashby J; Jevons G; Fraise A; Fry P; Warrington S; Hawser S; Wise R
    J Antimicrob Chemother; 2007 Sep; 60(3):677-80. PubMed ID: 17623694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals.
    Womble AY; Giguère S; Lee EA; Vickroy TW
    Am J Vet Res; 2006 Oct; 67(10):1681-6. PubMed ID: 17014316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
    Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
    J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
    Togami K; Chono S; Morimoto K
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages.
    Ikawa K; Kikuchi E; Kikuchi J; Nishimura M; Derendorf H; Morikawa N
    J Clin Pharm Ther; 2014 Aug; 39(4):411-7. PubMed ID: 24661290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
    Conte JE; Golden JA; McIver M; Little E; Zurlinden E
    Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.
    Togami K; Chono S; Morimoto K
    Biopharm Drug Dispos; 2011 Oct; 32(7):389-97. PubMed ID: 21812004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem.
    Conte JE; Golden JA; Kelley MG; Zurlinden E
    Int J Antimicrob Agents; 2005 Dec; 26(6):449-56. PubMed ID: 16280244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid.
    Yamazaki K; Ogura S; Ishizaka A; Oh-hara T; Nishimura M
    Am J Respir Crit Care Med; 2003 Dec; 168(11):1304-7. PubMed ID: 12904323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.
    Zhang J; Xie X; Zhou X; Chen YQ; Yu JC; Cao GY; Wu XJ; Shi YG; Zhang YY
    J Clin Pharmacol; 2010 Aug; 50(8):922-8. PubMed ID: 20035039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.
    Sun J; Deguchi Y; Tauchi Y; He Z; Cheng G; Morimoto K
    Eur J Pharm Biopharm; 2006 Oct; 64(2):238-45. PubMed ID: 16875808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with Mycobacterium avium complex pulmonary disease.
    Hasegawa N; Nishimura T; Watabnabe M; Tasaka S; Nakano Y; Yamazaki K; Hashimoto S; Nishimura M; Ishizaka A
    Pulm Pharmacol Ther; 2009 Jun; 22(3):190-3. PubMed ID: 19061965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects.
    Chandorkar G; Huntington JA; Gotfried MH; Rodvold KA; Umeh O
    J Antimicrob Chemother; 2012 Oct; 67(10):2463-9. PubMed ID: 22773741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline.
    Conte JE; Golden JA; Kelly MG; Zurlinden E
    Int J Antimicrob Agents; 2005 Jun; 25(6):523-9. PubMed ID: 15885987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.